Literature DB >> 1972766

The natural history of multiple endocrine neoplasia type 2A--a clinical analysis.

T Shimotake1, N Iwai, J Yanagihara, G Suzuki, S Takai.   

Abstract

The records of 18 patients with multiple endocrine neoplasia (MEN) type 2A in a family consisting of 87 members in 5 generations, were reviewed with respect to age at onset and length of survival in a study of the natural history of this syndrome. Of these 18 patients, 8 were alive following surgical treatment, while 10 had died without treatment. The clinical onset of medullary thyroid carcinoma was noticed as a nodule in the neck at between 17 and 34 years of age (mean 24 years); the onset of pheochromocytoma was characterized by palpitation, hypertensive attacks or recurrent headache at between 17 and 42 years of age (mean 27 years); and death occurred in 10 patients at between 23 and 67 years of age (mean 40.6 years). This information on the age at onset of individual clinical manifestations, and on the length of survival of gene carriers, may be useful for clinicians who are asked to assess the risk of the development of this syndrome in a genetically predisposed asymptomatic individual, because screening tests are often refused by members of Japanese families with MEN type 2A.

Entities:  

Mesh:

Year:  1990        PMID: 1972766     DOI: 10.1007/bf02470663

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  8 in total

1.  Multiple endocrine neoplasia type 2 syndromes in Japan.

Authors:  S Takai; A Miyauchi; H Matsumoto; T Ikeuchi; T Miki; K Kuma; Y Kumahara
Journal:  Henry Ford Hosp Med J       Date:  1984

2.  Impact of screening on prognosis in the multiple endocrine neoplasia type 2 syndromes: natural history and treatment results in 105 patients.

Authors:  M Telenius-Berg; B Berg; B Hamberger; S Tibblin; L E Tisell; L Ysander; G Welander
Journal:  Henry Ford Hosp Med J       Date:  1984

3.  Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage.

Authors:  N E Simpson; K K Kidd; P J Goodfellow; H McDermid; S Myers; J R Kidd; C E Jackson; A M Duncan; L A Farrer; K Brasch
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

4.  A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10.

Authors:  C G Mathew; K S Chin; D F Easton; K Thorpe; C Carter; G I Liou; S L Fong; C D Bridges; H Haak; A C Kruseman
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

5.  Total thyroidectomy for occult familial medullary carcinoma of the thyroid in children.

Authors:  L L Leape; H H Miller; K Graze; Z T Feldman; R F Gagel; H J Wolfe; R A Delellis; A H Tashjian; S Reichlin
Journal:  J Pediatr Surg       Date:  1976-10       Impact factor: 2.545

6.  The early diagnosis of medullary carcinoma of the thyroid gland in patients with multiple endocrine neoplasia type II.

Authors:  S A Wells; D A Ontjes; C W Cooper; J F Hennessy; G J Ellis; H T McPherson; D C Sabiston
Journal:  Ann Surg       Date:  1975-10       Impact factor: 12.969

7.  The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience.

Authors:  R F Gagel; A H Tashjian; T Cummings; N Papathanasopoulos; M M Kaplan; R A DeLellis; H J Wolfe; S Reichlin
Journal:  N Engl J Med       Date:  1988-02-25       Impact factor: 91.245

8.  Results of early thyroidectomy for medullary thyroid carcinoma in children with multiple endocrine neoplasia type 2.

Authors:  R L Telander; D Zimmerman; J A van Heerden; G W Sizemore
Journal:  J Pediatr Surg       Date:  1986-12       Impact factor: 2.545

  8 in total
  1 in total

1.  Pheochromocytoma in an 8-year-old patient with multiple endocrine neoplasia type 2A: implications for screening.

Authors:  Kathryn J Rowland; Rebecca D Chernock; Jeffrey F Moley
Journal:  J Surg Oncol       Date:  2013-07-19       Impact factor: 3.454

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.